News & Updates
On February 25th, we hosted our virtual networking meeting focused on the complexities of imaging based clinical trials. Thank you to everyone who participated in this exciting discussion. For those of you who wanted to join but could not, you can watch the recording below, and also register for our upcoming meetings! Register for the…
Read MoreExcerpt from the Article: Radiologists can classify breast lesions more accurately if they use artificial intelligence algorithms fueled by 4D data captured with dynamic contrasted-enhanced MRI (DCE-MRI), new research has found. In a study published on Feb. 24 in Radiology: Artificial Intelligence, investigators from the University of Chicago outlined their method for fusing the 4D…
Read MoreExcerpt from the Article: Using automated machine learning to calculate the right ventricle/left ventricle (RV/LV) ratio can help radiologists identify patients who have pulmonary hypertension (PH) and would benefit from being referred to a specialist. In a presentation during the 2021 European Congress of Radiology annual meeting, Pia Charters from Royal United Hospital Bath NHS…
Read MoreExcerpt from the Article: As the COVID-19 pandemic enters its second year, scientists are still working to understand how the SARS-CoV-2 strain evolved, and how it became so much more dangerous than other coronaviruses, which humans have been living alongside for millennia. Virologists and epidemiologists worldwide have speculated for months that a protein called ORF8…
Read MoreExcerpt from the Press Release: EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced today that its discovery engine has isolated potent antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant (B.1.351), in pseudovirus testing. This…
Read MoreExcerpt from the Press Release: LEXINGTON, Mass., Feb. 18, 2021 /PRNewswire/ — Partner Therapeutics, Inc. (PTx), a commercial biotech company, announces publication of two pivotal studies that provided the basis for approval of Leukine (sargramostim, yeast-derived rhu GM-CSF) to improve survival in patients exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome…
Read MoreExcerpt from the Press Release: OXFORDSHIRE, England and CONSHOHOCKEN, Pa. and ROCKVILLE, Md., Feb. 19, 2021 (GLOBE NEWSWIRE) — Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today…
Read MoreExcerpt from the Article: MRI scans reveal myocarditis, scarring, infarction, and ischemia in recovered patients with elevated troponin levels. Roughly 50 percent of patients who recover after being hospitalized with severe COVID-19 suffer heart damage. MRI scans, conducted at least one month post-discharge, show patients who have elevated levels of troponin show evidence of heart…
Read MoreExcerpt from the Press Release: Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting concerns about the prospects of long-lasting immunity and efficacy of COVID-19 vaccines. In a PLOS ONE paper, published online February 11, 2021, researchers at University of California San Diego School…
Read MoreExcerpt from the Article: CT, MRI, and ultrasound images reveal the myriad of ways the virus prompts the body to attack itself – with this knowledge, radiologists can better contribute to treatment planning. Not only does COVID-19 attack the body, but radiology images show that the virus can actually make the body attack itself. For…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?